medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2021, Número 4

<< Anterior

Cir Card Mex 2021; 6 (4)


Cox-maze procedure: One-size-fits-all for different choices. Concomitant and stand-alone atrial fibrillation. Techniques and evolution

García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 101
Paginas: 93-104
Archivo PDF: 455.29 Kb.


RESUMEN

El procedimiento de Cox-maze es una técnica quirúrgica que ha sido especialmente diseñada para eliminar todas las posibles causas de fibrilación auricular (FA) o flutter. Está compuesto por un conjunto de incisiones quirúrgicas o líneas de quemaduras estratégicamente colocadas en ambas aurículas, de manera que el impulso eléctrico se pueda conducir desde el nódulo sinusal al atrioventricular, conservando la función contráctil y de transporte de ambas aurículas. Con el flujo y reflujo incesante actual hacia técnicas quirúrgicas mínimamente invasivas, existen varias posibilidades de realizar el procedimiento de Cox-maze. El procedimiento de Cox-maze endocárdico, la ablación quirúrgica epicárdica, el procedimiento híbrido y el procedimiento convergente son solo un mero ejemplo de este tipo de procedimientos. Mientras que el abordaje de la FA concomitante es mediante procedimientos con bomba, en el caso de la FA asilada es eminentemente a través de técnicas sin bomba. En este artículo, buscamos revisar el estado actual y las aplicaciones para el procedimiento de Cox-maze de acuerdo con el tipo de FA, como FA concomitante o aislada.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wyndham CR. Atrial fibrillation: the most common arrhythmia. Tex HeartInst J. 2000;27(3):257-67.

  2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillationin adults: national implications for rhythm management and stroke prevention:the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)Study. JAMA. 2001;285(18):2370-5. doi: 10.1001/jama.285.18.2370.

  3. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence ofatrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implicationson the projections for future prevalence external icon. Circulation.2006;114:199–225. doi: 10.1161/CIRCULATIONAHA.105.595140.

  4. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of currentand future incidence and prevalence of atrial fibrillation in the U.S. adultpopulation. Am J Cardiol. 2013 Oct 15;112(8):1142-7. doi: 10.1016/j.amjcard.2013.05.063.

  5. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillationin adults: national implications for rhythm management and stroke prevention:the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA)Study. JAMA. 2001;285(18):2370-5. doi: 10.1001/jama.285.18.2370.

  6. https://www.cdc.gov/heartdisease/atrial_fibrillation.htm. Last accessed August10, 2021.

  7. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis,and predisposing conditions for atrial fibrillation: population-based estimates.Am J Cardiol 1998;82:2N-9N.

  8. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillationand congestive heart failure and their joint influence on mortality: the FraminghamHeart Study. Circulation 2003;107:2920-5.

  9. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation:incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.Am J Med 1995;98:476-84.

  10. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-termrisks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64.

  11. Ott A, Breteler MM, de Bruyne MC, et al. Atrial fibrillation and dementia ina population-based study. The Rotterdam Study. Stroke 1997;28:316-21.

  12. Proietti R, Hadjis A, AlTurki A, et al. A Systematic Review on the Progressionof Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light onthe Effects of Catheter Ablation. JACC Clin Electrophysiol. 2015;1(3):105-115. doi: 10.1016/j.jacep.2015.04.010.

  13. Badhwar V, Rankin JS, Ad N, et al. Surgical Ablation of Atrial Fibrillationin the United States: Trends and Propensity Matched Outcomes. Ann ThoracSurg. 2017;104(2):493-500. doi: 10.1016/j.athoracsur.2017.05.016.

  14. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electricalremodeling due to atrial fibrillation in chronically instrumented consciousgoats: roles of neurohumoral changes, ischemia, atrial stretch, and high rateof electrical activation. Circulation. 1997; 96(10):3710-20.

  15. Allessie MA. Atrial electrophysiologic remodeling: another vicious circle? JCardiovasc Electrophysiol. 1998; 9(12):1378-93.

  16. Cox JL. Atrial fibrillation I: a new classification system. J Thorac CardiovascSurg. 2003 Dec;126(6):1686-92. doi: 10.1016/j.jtcvs.2003.06.002.

  17. Cox JL. A brief overview of surgical for atrial fibrillation. Ann CardiothoracSurg 2014;3(1):80-8. doi: 10.3978/j.issn.2225-319X.2014.01.05.

  18. Cox JL, Malaisrie SC, Kislitsina ON, McCarthy PM. The electrophysiologicbasis for lesions of the contemporary Maze operation. J Thorac CardiovascSurg. 2019;157(2):584-590. doi: 10.1016/j.jtcvs.2018.08.007.

  19. Cox JL, Boineau JP, Schuessler RB, et al. Electrophysiologic basis, surgicaldevelopment, and clinical results of the maze procedure for atrial flutter andatrial fibrillation. Adv Card Surg. 1995;6:1-67.

  20. Cox JL. The first Maze procedure. J Thorac Cardiovasc Surg.2011;141(5):1093-7. doi: 10.1016/j.jtcvs.2010.12.012.

  21. Melby SJ, Zierer A, Bailey MS, et al. A new era in the surgical treatmentof atrial fibrillation: the impact of ablation technology and lesion set onprocedural efficacy. Ann Surg. 2006;244(4):583-92. doi: 10.1097/01.sla.0000237654.00841.26.

  22. García-Villarreal OA. Garcia-Villarreal OA. eComment. Alternative energysources in surgery for atrial fibrillation. Interact Cardiovasc Thorac Surg.2012;15(1):128. doi: 10.1093/icvts/ivs239.

  23. Ad N, Damiano RJ Jr, Badhwar V, Calkins H, La Meir M, Nitta T, Doll N,Holmes SD, Weinstein AA, Gillinov M. Expert consensus guidelines: Examiningsurgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg.2017;153(6):1330-1354.e1. doi: 10.1016/j.jtcvs.2017.02.027.

  24. Okada M, Usui A, Sakurai T, et al. Comparative study between cryoablationand radiofrequency ablation for surgical intervention of atrial fibrillation associatedwith mitral valve disease. Kyobu Geka. 2010;63(4):297-302.

  25. Camm CF, Nagendran M, Xiu PY, Maruthappu M. How effective is cryoablationfor atrial fibrillation during concomitant cardiac surgery? Interact CardiovascThorac Surg. 2011;13(4):410-4. doi: 10.1510/icvts.2011.271676.

  26. Cai W, Hu J, Wang H, Chen S, Zhu G, Chen X. Valve surgery in combinationwith cryoablation in the treatment of atrial fibrillation. Pak J Med Sci.2018;34(6):1402-1407. doi: 10.12669/pjms.346.15537.

  27. Cox JL, Malaisrie SC, Churyla A, et al. Cryosurgery for Atrial Fibrillation:Physiologic Basis for Creating Optimal Cryolesions. Ann Thorac Surg.2021;112(2):354-362. doi: 10.1016/j.athoracsur.2020.08.114.

  28. Nagashima K, Watanabe I, Okumura Y, et al. Epicardial ablation with irrigatedelectrodes: – effect of bipolar vs. unipolar ablation on lesion formation –.Circ J. 2012;76(2):322-7. doi: 10.1253/circj.cj-11-0984.

  29. Nagashima K, Watanabe I, Okumura Y, Ohkubo K, Kofune M, Ohya T, KasamakiY, Hirayama A. Lesion formation by ventricular septal ablation withirrigated electrodes: comparison of bipolar and sequential unipolar ablation.Circ J. 2011;75(3):565-70. doi: 10.1253/circj.cj-10-0870.

  30. Koruth JS, Dukkipati S, Miller MA, Neuzil P, d'Avila A, Reddy VY. Bipolar irrigatedradiofrequency ablation: a therapeutic option for refractory intramuralatrial and ventricular tachycardia circuits. Heart Rhythm. 2012;9(12):1932-41. doi: 10.1016/j.hrthm.2012.08.001.

  31. Varzaly JA, Chapman D, Lau DH, Edwards S, Louise J, Edwards J, MahajanR, Worthington M, Sanders P. Contact force and ablation assessment of surgicalbipolar radiofrequency clamps in the treatment of atrial fibrillation. InteractCardiovasc Thorac Surg. 2019;28(1):85-93. doi: 10.1093/icvts/ivy191.

  32. Khiabani AJ, MacGregor RM, Manghelli JL, Ruaengsri C, Carter DI, MelbySJ, Schuessler RB, Damiano RJ Jr. Bipolar Radiofrequency Ablation on ExplantedHuman Hearts: How to Ensure Transmural Lesions. Ann Thorac Surg.2020;110(6):1933-1939. doi: 10.1016/j.athoracsur.2020.04.079.

  33. Ad N, Holmes SD, Rongione AJ, Massimiano PS, Fornaresio LM. Does SurgicalAblation Energy Source Affect Long-Term Success of the ConcomitantCox Maze Procedure? Ann Thorac Surg. 2017;104(1):29-35. doi: 10.1016/j.athoracsur.2017.04.004.

  34. Musci M, Pasic M, Siniawski H, Lehmkuhl H, Edelmann B, Hetzer R. “Cox/Maze-III operation” as surgical therapy of chronic atrial fibrillation duringmitral valve and atrial septal defect II operation. Z Kardiol. 1998;87(3):202-8. [German]. doi: 10.1007/s003920050172.

  35. Arcidi JM Jr, Doty DB, Millar RC. The Maze procedure: the LDS Hospitalexperience. Semin Thorac Cardiovasc Surg. 2000;12(1):38-43. doi: 10.1016/s1043-0679(00)70015-3.

  36. Schaff HV, Dearani JA, Daly RC, Orszulak TA, Danielson GK. Cox-Mazeprocedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac CardiovascSurg. 2000;12(1):30-7. doi: 10.1016/s1043-0679(00)70014-1.

  37. McCarthy PM, Gillinov AM, Castle L, Chung M, Cosgrove D 3rd. The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac CardiovascSurg. 2000;12(1):25-9. doi: 10.1016/s1043-0679(00)70013-x.

  38. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-SaranoM. Outcome of valve repair and the Cox maze procedure for mitralregurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg.1999;118(4):628-35. doi: 10.1016/S0022-5223(99)70007-3.

  39. Wang CT, Zhang L, Qin T, et al. Cox-maze III procedure for atrial fibrillationduring valve surgery: a single institution experience. J Cardiothorac Surg2020; 15; 111. https://doi.org/10.1186/s13019-020-01165-4.

  40. Stulak JM, Sundt TM 3rd, Dearani JA, Daly RC, Orsulak TA, Schaff HV.Ten-year experience with the Cox-maze procedure for atrial fibrillation: howdo we define success? Ann Thorac Surg. 2007;83(4):1319-24. doi:10.1016/j.athoracsur.2006.11.007.

  41. García-Villarreal OA. Efectividad del procedimiento de Cox-maze III a largoplazo y su relación con el tamaño posoperatorio de la aurícula izquierda. GacMed Mex. 2019;155(6):590-5. doi: 10.24875/GMM.19005385.

  42. Ad N, Henry L, Hunt S, Holmes SD. Do we increase the operative risk byadding the Cox Maze III procedure to aortic valve replacement and coronaryartery bypass surgery? J Thorac Cardiovasc Surg. 2012;143(4):936-44. doi:10.1016/j.jtcvs.2011.12.018.

  43. Gomes GG, Gali WL, Sarabanda AVL, Cunha CRD, Kessler IM, Atik FA.Late Results of Cox Maze III Procedure in Patients with Atrial FibrillationAssociated with Structural Heart Disease. Arq Bras Cardiol. 2017;109(1):14-22. doi: 10.5935/abc.20170082.

  44. Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2-year clinical experiencewith surgery for atrial fibrillation. Ann Surg. 1996;224(3):267-73;discussion 273-5. doi: 10.1097/00000658-199609000-00003.

  45. Schill MR, Musharbash FN, Hansalia V, Greenberg JW, Melby SJ, ManiarHS, Sinn LA, Schuessler RB, Moon MR, Damiano RJ Jr. Late results ofthe Cox-maze IV procedure in patients undergoing coronary artery bypassgrafting. J Thorac Cardiovasc Surg. 2017;153(5):1087-1094. doi: 10.1016/j.jtcvs.2016.12.034.

  46. Lawrance CP, Henn MC, Miller JR, Sinn LA, Schuessler RB, Damiano RJ Jr.Comparison of the stand-alone Cox-Maze IV procedure to the concomitantCox-Maze IV and mitral valve procedure for atrial fibrillation. Ann CardiothoracSurg. 2014;3(1):55-61. doi:10.3978/j.issn.2225-319X.2013.12.09

  47. Weimar T, Schena S, Bailey MS, Maniar HS, Schuessler RB, Cox JL, DamianoRJ Jr. The cox-maze procedure for lone atrial fibrillation: a single-centerexperience over 2 decades. Circ Arrhythm Electrophysiol. 2012;5(1):8-14.doi: 10.1161/CIRCEP.111.963819.

  48. Henn MC, Lancaster TS, Miller JR, et al. Late outcomes after the Cox maze IVprocedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2015;150(5):1168-76, 1178.e1-2. doi: 10.1016/j.jtcvs.2015.07.102.

  49. Ad N, Holmes SD, Stone LE, Pritchard G, Henry L. Rhythm course over 5years following surgical ablation for atrial fibrillation. Eur J CardiothoracSurg. 2015 Jan;47(1):52-8; discussion 58. doi: 10.1093/ejcts/ezu059.

  50. Khiabani AJ, MacGregor RM, Bakir NH, et al. The long-term outcomesand durability of the Cox-Maze IV procedure for atrial fibrillation. JThorac Cardiovasc Surg. 2020:S0022-5223(20)31065-5. doi: 10.1016/j.jtcvs.2020.04.100.

  51. Trofimov NA, Medvedev AP, Babokin VE, et al. Effectiveness of the CoxMaze-IV Procedure in Cardiac Surgery Patients with Atrial Fibrillation. Kardiologiia.2020 Jun 3;60(5):991.

  52. McGilvray MMO, Bakir NH, et al. Efficacy of the stand-alone Cox-Maze IVprocedure in patients with longstanding persistent atrial fibrillation. J CardiovascElectrophysiol. (2021). doi: 10.1111/jce.15113.

  53. Damiano RJ Jr, Badhwar V, Acker MA, et al. The CURE-AF trial: a prospective,multicenter trial of irrigated radiofrequency ablation for the treatmentof persistent atrial fibrillation during concomitant cardiac surgery. HeartRhythm. 2014;11(1):39-45. doi: 10.1016/j.hrthm.2013.10.004.

  54. Garcia-Villarreal OA. eComment. "Electric" Cox-maze IV with bipolar radiofrequency:toward full transmurality. Interact Cardiovasc Thorac Surg.2012;14(6):847. doi: 10.1093/icvts/ivs156.

  55. Damiano RJ Jr, Bailey M. The Cox-Maze IV procedure for lone atrial fibrillation.Multimed Man Cardiothorac Surg. 2007;2007(723):mmcts.2007.002758.doi: 10.1510/mmcts.2007.002758.

  56. Robertson JO, Saint LL, Leidenfrost JE, Damiano RJ Jr. Illustrated techniquesfor performing the Cox-Maze IV procedure through a right mini-thoracotomy.Ann Cardiothorac Surg. 2014;3(1):105-16. doi: 10.3978/j.issn.2225-319X.2013.12.11.

  57. Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons2017 Clinical Practice Guidelines for the Surgical Treatment of AtrialFibrillation. Ann Thorac Surg. 2017;103(1):329-341. doi: 10.1016/j.athoracsur.2016.10.076.

  58. Garcia-Villarreal OA. How to Correctly Perform the Cox-Maze IV Procedure:From the Theory into the Practice. Part I. Surgical Technique. Int J SurgProced. 2020;3(1):131. doi: 10.31021/ijsp.2020313.

  59. Ad N, Henry L, Friehling T, Wish M, Holmes SD. Minimally invasive standaloneCox-maze procedure for patients with nonparoxysmal atrial fibrillation.Ann Thorac Surg. 2013;96(3):792-8; discussion 798-9. doi: 10.1016/j.athoracsur.2013.05.007.

  60. Je HG, Shuman DJ, Ad N. A systematic review of minimally invasive surgicaltreatment for atrial fibrillation: a comparison of the Cox-Maze procedure,beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy.Eur J Cardiothorac Surg. 2015;48(4):531-40; discussion 540-1. doi:10.1093/ejcts/ezu536.

  61. Ad N, Holmes SD, Friehling T. Minimally Invasive Stand-Alone Cox MazeProcedure for Persistent and Long- Standing Persistent Atrial FibrillationPerioperative Safety and 5-Year Outcomes. Circ Arrhythm Electrophysiol.2017;10:e005352. doi: 10.1161/CIRCEP.117.005352.

  62. Schill MR, Sinn LA, Greenberg JW, et al. A Minimally Invasive Stand-aloneCox-Maze Procedure Is as Effective as Median Sternotomy Approach. Innovations(Phila). 2017;12(3):186-191. doi: 10.1097/IMI.0000000000000374.

  63. Lawrance CP, Henn MC, Miller JR, et al. A minimally invasive Cox maze IVprocedure is as effective as sternotomy while decreasing major morbidity andhospital stay. J Thorac Cardiovasc Surg. 2014;148(3):955-62. doi:10.1016/j.jtcvs.2014.05.064.

  64. Saint LL, Damiano RJ Jr, Cuculich PS, et al.Incremental risk of the CoxmazeIV procedure for patients with atrial fibrillation undergoing mitralvalve surgery. J Thorac Cardiovasc Surg. 2013;146(5):1072-7. doi: 10.1016/j.jtcvs.2013.06.048.

  65. Jiang Z, Tang M, Ma N, Liu H, Ding F, Bao C, Mei J. Right minithoracotomyversus conventional median sternotomy for patients undergoing mitralvalve surgery and Cox-maze IV ablation with entirely bipolar radiofrequencyclamp. Heart Vessels. 2018;33(8):901-907. doi: 10.1007/s00380-018-1126-4.

  66. Voeller RK, Bailey MS, Zierer A, et al. Isolating the entire posterior left atriumimproves surgical outcomes after the Cox maze procedure. J Thorac CardiovascSurg. 2008;135(4):870-7. doi: 10.1016/j.jtcvs.2007.10.063.

  67. Garcia-Villarreal OA. Pulmonary vein isolation for persistent atrial fibrillation.Long-term results. Asian Cardiovasc Thorac Ann. 2015;23(6):665-9.doi: 10.1177/0218492315581265.

  68. Garcia-Villarreal OA. eComment. Pulmonary vein isolation is not enough totreat long-standing persistent atrial fibrillation. Interact Cardiovasc ThoracSurg. 2016;23(2):299. doi: 10.1093/icvts/ivw139.

  69. Cox JL. The longstanding, persistent confusion surrounding surgery for atrialfibrillation. J Thorac Cardiovasc Surg. 2010;139(6):1374-86. doi: 10.1016/j.jtcvs.2010.02.027.

  70. Cox JL, Churyla A, Malaisrie SC, et al. When Is a Maze Procedure a MazeProcedure? Can J Cardiol. 2018 Nov;34(11):1482-1491. doi: 10.1016/j.cjca.2018.05.008.

  71. Garcia-Villarreal OA. The Maze that is not Maze: It is not filling the gap!Surg Med Open Acc J. (2020), 3(3). SMOAJ.000565.2020.

  72. García-Villarreal OA. The Cox-maze procedure: rules not to be broken.Ann Thorac Surg. 2021:S0003-4975(21)00345-3. doi: 10.1016/j.athoracsur.2021.02.026.

  73. García-Villarreal OA. The Cox-maze procedure: accuracy and completenessdo matter. Ann Thorac Surg. 2021:S0003-4975(21)00504-X. doi: 10.1016/j.athoracsur.2021.03.007.

  74. Kurfirst V, Mokráček A, Budera P, Straka Z, Pojar M, Harrer J. The currenttechnical options for minimally invasive surgical treatment of atrial fibrillation,Cor et Vasa (2017), http://dx.doi.org/10.1016/j.crvasa.2017.06.007

  75. Van Laar C, Geuzebroek GSC, Hofman FN, van Putte BP. The totally thoracoscopicleft atrial maze procedure for the treatment of atrial fibrillation.Multimed Man Cardiothorac Surg 2016;2016, doi:10.1093/mmcts/mmv043.

  76. Sakamoto S, Voeller RK, Melby SJ, et al. Surgical ablation for atrial fibrillation:the efficacy of a novel bipolar pen device in the cardioplegically arrestedand beating heart. J Thorac Cardiovasc Surg. 2008;136(5):1295-301. doi:10.1016/j.jtcvs.2008.04.030.

  77. Bulava A, Mokracek A, Hanis J, Kurfirst V, Eisenberger M, Pesl L. Sequentialhybrid procedure for persistent atrial fibrillation. J Am Heart Assoc.2015;4(3):e001754. doi: 10.1161/JAHA.114.001754.

  78. Verberkmoes NJ, Olsthoorn JR, Dekker LRC. Minimally invasive totally thoracoscopicstand-alone surgical ablation for atrial fibrillation. Multimed ManCardiothorac Surg 2020; doi: 10.1510/mmcts.2020.011.

  79. Haywood GA, Varini R, Osmancik P, et al. European multicentre experienceof staged hybrid atrial fibrillation ablation for the treatment of persistentand longstanding persistent atrial fibrillation. Int J Cardiol Heart Vasc.2020;26:100459. doi: 10.1016/j.ijcha.2019.100459.

  80. Compier MG, Braun J, Tjon A, et al. Outcome of stand-alone thoracoscopicepicardial left atrial posterior box isolation with bipolar radiofrequencyenergy for longstanding persistent atrial fibrillation. Neth Heart J.2016;24(2):143-151. doi:10.1007/s12471-015-0785-3.

  81. Doty JR, Clayson SE. Surgical Treatment of Isolated (Lone) Atrial Fibrillationwith Gemini-S Ablation and Left Atrial Appendage Excision (GALAXYProcedure). Innovations 2012;7(1):33-38.

  82. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrialfibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131(5):1029-35. doi: 10.1016/j.jtcvs.2005.10.020.

  83. Cox JL. Surgical Ablation for Atrial Fibrillation. N Engl J Med.2015;373(5):483. doi: 10.1056/NEJMc1506893.

  84. Ruaengsri C, Schill MR, Khiabani AJ, Schuessler RB, Melby SJ, DamianoRJ Jr. The Cox-maze IV procedure in its second decade: still the gold standard?Eur J Cardiothorac Surg. 2018;53(suppl_1):i19-i25. doi: 10.1093/ejcts/ezx326.

  85. García-Villarreal OA. Cox-maze III procedure for atrial fibrillation. A preliminarystudy. Arch Cardiol Mex. 2016;86(3):208-13. [Spanish]. doi: 10.1016/j.acmx.2016.02.003.

  86. García-Villarreal OA. Mini-partial heart autotransplantation: a differentway to perform the Cox-maze III. Interact Cardiovasc Thorac Surg.2015;21(2):147-50. doi: 10.1093/icvts/ivv121.

  87. Cox JL, Churyla A, Malaisrie SC, et al. A Hybrid Maze Procedurefor Long-Standing Persistent Atrial Fibrillation. Ann Thorac Surg.2019;107(2):610-618. doi: 10.1016/j.athoracsur.2018.06.064.

  88. Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M,Sandoval E, Calvo N, Brugada J, Kelder J, Wijffels M, Mont L. Atrial fibrillationcatheter ablation versus surgical ablation treatment (FAST): a 2-centerrandomized clinical trial. Circulation. 2012;125(1):23-30. doi: 10.1161/CIRCULATIONAHA.111.074047.

  89. Kim HJ, Kim JS, Kim TS. Epicardial thoracoscopic ablation versus endocardialcatheter ablation for management of atrial fibrillation: a systematic reviewand meta-analysis. Interact CardioVasc Thorac Surg 2016; doi:10.1093/icvts/ivw027.

  90. Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, AragonD, Nuñez M, Sandoval E, Casellas A, Mont L, van Boven WJ, Boersma LVA,van Putte BP. Thoracoscopic vs. catheter ablation for atrial fibrillation: longtermfollow-up of the FAST randomized trial. Europace. 2019; 21(5):746-753. doi: 10.1093/europace/euy325.

  91. Phan K, Phan S, Thiagalingam A, Medi C, Yan TD. Thoracoscopic surgicalablation versus catheter ablation for atrial fibrillation. Eur J CardiothoracSurg 2015; doi:10.1093/ejcts/ezv180.

  92. Sindby JE, Vadmann H, Lundbye-Christensen S, et al. Percutaneous versusthoracoscopic ablation of symptomatic paroxysmal atrial fibrillation:a randomised controlled trial - the FAST II study. J Cardiothorac Surg.2018;13(1):101. doi:10.1186/s13019-018-0792-8.

  93. Wang TKM, Liao YB, Wang MTM, Martin A. Catheter vs thoracoscopic ablationfor atrial fibrillation: Meta-analysis of randomized trials. J Arrhythm.2020 Jul 3;36(4):789-793. doi: 10.1002/joa3.12394.

  94. Haywood GA, Varini R, Osmancik P, et al. European multicentre experience ofstaged hybrid atrial fibrillation ablation for the treatment of persistent and longstandingpersistent atrial fibrillation. Int J Cardiol Heart Vasc. 2020;26:100459.doi: 10.1016/j.ijcha.2019.100459.

  95. Al-Jazairi MIH, Rienstra M, Klinkenberg TJ, Mariani MA, Van Gelder IC, BlaauwY. Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation orfailed catheter ablation. Neth Heart J. 2019;27(3):142-151. doi: 10.1007/s12471-019-1228-3.

  96. Pojar M, Haman L, Parizek P, Myjavec A, Gofus J, Vojacek J. Midterm outcomesof mini-invasive surgical and hybrid ablation of atrial fibrillation. BiomedPap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(3):233-240. doi:10.5507/bp.2018.050.

  97. Budera P, Osmancik P, Herman D, et al. Midterm outcomes of two-staged hybridablation of persistent and long-standing persistent atrial fibrillation using the versapolarepicardial surgical device and subsequent catheter ablation. J Interv CardElectrophysiol. 2017;50(2):187-194. doi: 10.1007/s10840-017-0286-y.

  98. DeLurgio DB, Crossen KJ, Gill J, et al. Hybrid Convergent Procedure for theTreatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results ofCONVERGE Clinical Trial. Circ Arrhythm Electrophysiol. 2020;13(12):e009288.doi: 10.1161/CIRCEP.120.009288.

  99. Ellis CR, Badhwar N, Tschopp D, et al. Subxiphoid Hybrid Epicardial-EndocardialAtrial Fibrillation Ablation and LAA Ligation: Initial Sub-X HybridMAZE Registry Results. JACC Clin Electrophysiol. 2020;6(13):1603-1615. doi:10.1016/j.jacep.2020.06.011.

  100. Ad N. The importance of standardization in surgical ablation for atrial fibrillation. JThorac Cardiovasc Surg. 2016;151(2):399-401. doi: 10.1016/j.jtcvs.2015.09.111.

  101. García-Villarreal OA. Standardization in maze procedure: a step towards abetter future. J Thorac Dis. 2018;10(Suppl 33):S3887-S3889. doi: 10.21037/jtd.2018.08.131.




2020     |     www.medigraphic.com